HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability.

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987) · Science · doi:10.1126/science.3798106 · Cited by 11,760

Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei

Dignam, J. D., Lebovitz, R. M., & Roeder, R. G. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.5.1475 · Cited by 11,262

Sequence and structure-based prediction of eukaryotic protein phosphorylation sites

Blom, N., Gammeltoft, S., & Brunak, S. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3310 · Cited by 3,212

The ErbB signaling network: receptor heterodimerization in development and cancer

Olayioye, M. A., Neve, R. M., Lane, H. A., & Hynes, N. E. (2000) · The EMBO Journal · doi:10.1093/emboj/19.13.3159 · Cited by 2,489

Molecular determinants of resistance to antiandrogen therapy

Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

Kato, S., Endoh, H., Masuhiro, Y., Kitamoto, T., Uchiyama, S., Sasaki, H., Masushige, S., Gotoh, Y., Nishida, E., Kawashima, H., et al. (1995) · Science · doi:10.1126/science.270.5241.1491 · Cited by 1,964

Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB

Yamamoto, K. K., Gonzalez, G. A., Biggs, W., & Montminy, M. (1988) · Nature · doi:10.1038/334494a0 · Cited by 1,281

A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase

Craft, N., Shostak, Y., Carey, M., & Sawyers, C. L. (1999) · Nature Medicine · doi:10.1038/6495 · Cited by 980

The ErbB2/ErbB3 heterodimer functions as an oncogenic unit: ErbB2 requires ErbB3 to drive breast tumor cell proliferation

Holbro, T., Beerli, R. R., Maurer, F., Koziczak, M., Barbas, C. F., & Hynes, N. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1537685100 · Cited by 952

Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.

Čulig, Z., Hobisch, A., Cronauer, M. V., Radmayr, C., Trapman, J., Hittmair, A., Bartsch, G., & Klocker, H. (1994) · PubMed · Cited by 938

Signalling Pathways and Gene Expression Profiles in Prostate Cancer

Hatziieremia, S., McCall, P., & Edwards, J. (2011) · InTech eBooks · doi:10.5772/26971

JSM Clinical Oncology and Research

Onishi, T., & Sasaki, T. (2014)

prostate cancer cells stability in the transition of androgen requirement in The significance of Her2 on androgen receptor protein

Hsu, F.-N., Yang, M.-S., Lin, E. C., Tseng, C.-F., & Lin, H. (2011)

Factor Analysis of Microarray Data

Xu, S. (2012) · Springer eBooks · doi:10.1007/978-0-387-70807-2_21

The Ron receptor tyrosine kinase in prostate cancer.

Thobe, M. N. (2010) · OhioLink ETD Center (Ohio Library and Information Network)

The Role of EGFR, HER 2-4, Heregulin and Downstream Signalling in Prostate Adenocarcinoma

Grimsley, S. J. S. (2008) · Enlighten: Theses (The University of Glasgow)

Amplification and Overexpression of ERBB2, uPA, TRPS1, EIF3S3 and MYC Genes in Prostate Cancer

Savinainen, K. (2006) · Tampere University Institutional Repository (Tampere University)

ANALYSIS OF ENDOTHELIN DURING ANDROGEN DEPRIVATION: IMPLICATIONS FOR PROSTATE CANCER PROGRESSION

D’Antonio, J. M. (2007) · D-Scholarship@Pitt (University of Pittsburgh)

Expanding the Role of EGFR Inhibitors in Prostate Cancer

Sridhar, S. S., & Moore, M. J. (2006) · Translational medicine series · doi:10.3109/9781420019858.013

Targeted Prostate Cancer Chemoprevention Trial with Tocotrienols

Stone, W., Palau, V. E., Campbell, S., & Krishnan, K. (2012) · CRC Press eBooks · doi:10.1201/b12502-9

Hsp90: A Target for Prostate Cancer Therapy

Solit, D. B., Scher, H. I., & Rosen, N. X. (2006) · Translational medicine series · doi:10.3109/9781420019858.016

Identification of new urine biomarkers for the detection of prostate cancer

Rigau, M. (2011) · TDX (Tesis Doctorals en Xarxa)

Examination of Prostate Cancer Stem-like Cell Associated Factors for their Contribution Towards the Development of Castration Resistant Prostate Cancer

Wong, N. (2016) · MacSphere (McMaster University) · doi:10.71548/15872

Characterising novel phosphatase enzymes important in regulating androgen receptor function in the progression of castrate resistant prostate cancer

Grey, J. (2017)

CHANGES OF ErbB-RELATED SURVIVAL SIGNALINGS BETWEEN ANDROGEN-DEPENDENT AND -INDEPENDENT TRANSITION OF PROSTATE CANCER CELLS

Hsu, F.-C., Yang, Y., & Lin, H. (2009)

Discovery Of Piperlongumine Derivatives As Anti-Leukemic And Anti-Prostate Cancer Agents

Liao, Y. (2018) · Human Biology

Molecular Biology and Prostate Cancer

Shaw, G. L., & Neal, D. E. (2012) · Springer eBooks · doi:10.1007/978-1-4471-2864-9_2

Faculty Opinions recommendation of Targeting androgen receptor in estrogen receptor-negative breast cancer.

Wang, C. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.12333956.13515054

Immunotherapy as a Precision Medicine Tool for the Treatment of Prostate Cancer

Adamaki, M., Vassilios, A., & undefined, Z. (2020) · Vide Leaf, Hyderabad eBooks · doi:10.37247/pacr.1.2020.39

HER3

Lugovskoy, A. A., Curley, M. D., Lahdenranta, J., Kalra, A. V., Czibere, A. G., MacBeath, G., & Schoeberl, B. (2015) · Springer eBooks · doi:10.1007/978-1-4614-6613-0_95-1

Faculty Opinions recommendation of Tumor Microenvironment-Derived NRG1 Promotes Antiandrogen Resistance in Prostate Cancer.

Bevan, C. L., & Constantin, T. A. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738340952.793583202

HER3

Lugovskoy, A. A., Curley, M. D., Lahdenranta, J., Kalra, A. V., Czibere, A. G., MacBeath, G., & Schoeberl, B. (2017) · Springer eBooks · doi:10.1007/978-1-4419-0717-2_95

Data from Post-Transcriptional Regulation of the Androgen Receptor by Mammalian Target of Rapamycin

Cinar, B., Benedetti, A. D., & Freeman, M. R. (2023) · doi:10.1158/0008-5472.c.6494625.v1

Data from Post-Transcriptional Regulation of the Androgen Receptor by Mammalian Target of Rapamycin

Cinar, B., Benedetti, A. D., & Freeman, M. R. (2023) · doi:10.1158/0008-5472.c.6494625

Data from EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance

Zhang, Y., Linn, D. E., Liu, Z., Melamed, J., Tavora, F. R. F., Young, C. Y., Burger, A. M., & Hamburger, A. W. (2023) · doi:10.1158/1535-7163.c.6531030

Data from EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance

Zhang, Y., Linn, D. E., Liu, Z., Melamed, J., Tavora, F. R. F., Young, C. Y. F., Burger, A. M., & Hamburger, A. W. (2023) · doi:10.1158/1535-7163.c.6531030.v1

Data from Nrdp1-Mediated Regulation of ErbB3 Expression by the Androgen Receptor in Androgen-Dependent but not Castrate-Resistant Prostate Cancer Cells

Chen, L., Siddiqui, S., Bose, S., Mooso, B. A., Asuncion, A., Bedolla, R. G., Vinall, R. L., Tepper, C. G., Gandour‐Edwards, R. F., Shi, X.-B., et al. (2023) · doi:10.1158/0008-5472.c.6500427

Data from Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression

Wang, G., Haile, S., Comuzzi, B., Tien, A. H., Wang, J., Yong, T. M. K., Jelescu-Bodos, A. E., Blaszczyk, N., Vessella, R. L., Masri, B. A., et al. (2023) · doi:10.1158/0008-5472.c.6499368.v1

Data from Dual EGFR/HER2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB3

Chen, L., Mooso, B. A., Jathal, M. K., Madhav, A., Johnson, S. D., Spyk, E. N. V., Mikhailova, M., Ripoll, A. Z., Xue, L., Vinall, R. L., et al. (2023) · doi:10.1158/1078-0432.c.6518943

Data from Dual EGFR/HER2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Withdrawal by Suppressing ErbB3

Chen, L., Mooso, B. A., Jathal, M. K., Madhav, A., Johnson, S. D., Spyk, E. N. V., Mikhailova, M., Ripoll, A. Z., Xue, L., Vinall, R. L., et al. (2023) · doi:10.1158/1078-0432.c.6518943.v1

Supplementary Table 2 from Osteoblast-Derived Factors Induce an Expression Signature that Identifies Prostate Cancer Metastasis and Hormonal Progression

Wang, G., Haile, S., Comuzzi, B., Tien, A. H., Wang, J., Yong, T. M. K., Jelescu-Bodos, A. E., Blaszczyk, N., Vessella, R. L., Masri, B. A., et al. (2023) · doi:10.1158/0008-5472.22379841.v1

Data from Wwox Suppresses Prostate Cancer Cell Growth through Modulation of ErbB2-Mediated Androgen Receptor Signaling

Qin, H. R., Iliopoulos, D., Nakamura, T., Costinean, S., Volinia, S., Druck, T., Sun, J., Okumura, H., & Huebner, K. (2023) · doi:10.1158/1541-7786.c.6542880

Data from Wwox Suppresses Prostate Cancer Cell Growth through Modulation of ErbB2-Mediated Androgen Receptor Signaling

Qin, H. R., Iliopoulos, D., Nakamura, T., Costinean, S., Volinia, S., Druck, T., Sun, J., Okumura, H., & Huebner, K. (2023) · doi:10.1158/1541-7786.c.6542880.v1

Data from ERBB3 Overexpression is Enriched in Diverse Patient Populations with Castration-sensitive Prostate Cancer and is Associated with a Unique AR Activity Signature

Vellky, J. E., Kirkpatrick, B. J., Gutgesell, L. C., Morales, M., Brown, R. M., Wu, Y., Maienschein‐Cline, M., Notardonato, L. D., Weinfeld, M. S., Nguyen, R. H.-T., et al. (2024) · doi:10.1158/1078-0432.c.7181266.v1

Crossroads of Signaling Pathways

Staibano, S. (2013) · Springer eBooks · doi:10.1007/978-94-007-7149-9_8

Somatic Genetic Changes in Prostate Cancer

Helenius, M. A., Waltering, K. K., & Visakorpi, T. (2008) · Humana Press eBooks · doi:10.1007/978-1-60327-079-3_5

Crosstalk between the epidermal growth factor receptor and androgen receptor signaling pathways in prostate cancer

Gregory, C. W. (2009) · Annual Review of Biomedical Sciences · doi:10.5016/1806-8774.2009v11pt102

Phase II Randomized Study of MK‐2206 and Bicalutamide in Prostate Cancer Patients With Rising PSA After Primary Therapy (ECOG‐ACRIN E2809)

Ferrari, A. C., Chen, Y., Rodriguez, R., Hudes, G. R., Antonarakis, E. S., Hahn, N. M., Ma, H., Plimack, E. R., Mayer, T. M., Carthon, B. C., et al. (2026) · The Prostate · doi:10.1002/pros.70125

Identification de nouveaux inhibiteurs de kinases pour le traitement des cancers de prostate résistants à la castration

Azzi, J. (2016) · theses.fr (ABES) · doi:10.70675/a7506c99zd8d9z412bz87dezacc141eb3932

Cancer de la prostate et mécanismes de résistance à la castration : étude du rôle des récepteurs nucléaires LXR

Bousset, L. (2019) · theses.fr (ABES) · doi:10.70675/45b0b676z18daz47a9zbb03zee607f300175

Cellular and molecular mechanisms underlying the role played by the MEN1 gene in prostate cancer cells

Luo, Y. (2021) · theses.fr (ABES) · doi:10.70675/2cb2dd05z5a31z4d0dzb763zebc97e929bad

IL-1β/IL-6 signaling circuit in the tumor microenvironment drives prostate cancer developmentPreprint

Lee, Y. S., Zhao, J. L., Chryplewicz, A., Land, M., Sharma, R., Chan, J., Smith, P., Kottapalli, S., Fong, L. E., Chen, Z., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.30.741572

Androgen Receptor Biology in Castration Resistant Prostate Cancer

Cheng, H. H., & Montgomery, B. (2014) · Current clinical urology · doi:10.1007/978-1-4939-1176-9_5

Inhibition of HER-2/neu Kinase Impairs Androgen Receptor Recruitment to the Androgen Responsive Enhancer

Liu, Y., Majumder, S., McCall, W., Sartor, C. I., Mohler, J. L., Gregory, C. W., Earp, H. S., & Whang, Y. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4292 · Cited by 99

Effect of type I growth factor receptor tyrosine kinase inhibitors on phosphorylation and transactivation activity of the androgen receptor in prostate cancer cells: Ligand-independent activation of the N-terminal domain of the androgen receptor

Sugita, S., Kawashima, H., Tanaka, T., Kurisu, T., Sugimura, K., & Nakatani, T. (2004) · Oncology Reports · doi:10.3892/or.11.6.1273 · Cited by 21

HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway.

Wen, Y., Hu, M. C. ‐., Makino, K., Spohn, B., Bartholomeusz, G. A., Yan, D., & Hung, M. (2000) · PubMed · Cited by 461

HER2/HER3 heterodimers in prostate cancer

Freeman, M. R. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.018 · Cited by 25

Androgen-Dependent Regulation of Her-2/neu in Prostate Cancer Cells

Berger, R., Lin, D. I., Nieto, M., Sicińska, E., Garraway, L. A., Adams, H., Signoretti, S., Hahn, W. C., & Loda, M. F. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3928 · Cited by 79